Miguel A Materin MD
Associate Professor of Ophthalmology and Visual Science; Director of Ophthalmic Oncology
Biographical Info

Dr. Materin joined the Yale University School of Medicine on January 1, 2009 as Director of Ophthalmic Oncology. He is an Associate Professor of Ophthalmology & Visual Science. His clinical practice involves diagnosis and treatment of patients with ocular tumors, including benign and malignant tumors of the eye. He has special interests in ocular melanoma, retinoblastoma, choroidal hemangiomas, retinal hemangioblastomas, metastases, astrocytic tumors and tumors related to other conditions or syndromes, like von Hippel Lindau disease, Tuberous Sclerosis among others. Dr. Materin is an internationally recognized ocular oncologist, serving as a member of the International Advisory Board (Ocular Oncology) for the Canadian Journal of Ophthalmology. He has published extensively in the peer-reviewed literature, including journals and book chapters. He has served as a visiting professor in US, Canada, Israel, Spain, Brazil, Puerto Rico, Argentina, and gave lectures worldwide. Dr. Materin has received the Achievement Award from the American Academy of Ophthalmology and he is a Member of Merit of Clinica Barraquer (Barcelona, Spain). He has served as Director of Diagnostic Studies at the Ocular Oncology Service at Wills Eye Hospital for 7 years. He is an active member of the International Society of Ocular Oncology, American Academy of Ophthalmology, Pan American Association of Ophthalmology and Argentine Society of Ophthalmology.
Education & Training
- M.D.
- Buenos Aires Natl. Univ. (1983)
- Resident
- Santa Lucia Hospital, Buenos Aires, Argentina, Ophthalmology (1984 - 1989)
- Fellow
- Wills Eye Hospital, Thomas Jefferson University, Ocular Oncology (1999 - 2000)
- Fellow
- Consultores Oftalmológicos, Buenos Aires, Argentina, Retina (1989 - 1991)
- Board Certification
- Ophthalmology, FB


